Wilmer Cutler Pickering Hale and Dorr LLP advised on the deal. Xeris Pharmaceuticals completed its public offerings of 7,400,000 shares of common stock of Xeris Pharmaceuticals,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now